Thought Leadership

Deeper perspectives on the industry from our Marbls Team

Maximizing Tendering Outcomes through Successful Value-based-Tendering

When Exclusivity Ends – The Pricing and Contracting Imperative

Navigating the Components of the IRA for Pharmaceutical Manufacturers – Part 3, Part D Redesign Program

Salesforce Agentforce – a gamechanger?

Navigating the Components of the IRA for Pharmaceutical Manufacturers – Part 2, The Inflation Reduction Act’s Inflationary Rebates and Their Impact on Pharmaceutical Manufacturers

Navigating the Components of the IRA for Pharmaceutical Manufacturers – Part 1, Drug Price Negotiation Program (Maximum Fair Price)

DTx – Digital Therapeutics

Text-AI Cookbook – Building a Question-Answering AI Solution Powered by Large Language Models

Sprinting Ahead – Pharma’s Race to Prepare for Europe’s New Joint Clinical Assessment (JCA) Regulation

Reimagining Pharma’s Commercial Approach

Successful Value Retention with Effective Loss of Exclusivity (LoE) Management